IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Orphan Disease Treatment Institute Co., Ltd.


USPTO Granted Patents = 4



Forward Citations = 101

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Makoto Koizumi (4 out of 49 patents)

silverMedal Masafumi Matsuo (4 out of 14 patents)

bronzeMedal Yasuhiro Takeshima (4 out of 6 patents)

4.  Masafumi Matsuo (0 patent)

5.  Makoto Koizumi (0 patent)

6.  Yasuhiro Takeshima (0 patent)


4 patents:

1. 9657050 - ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors (2017-05-23),
2. 9657049 - ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors (2017-05-23),
3. 9243026 - ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors (2016-01-26),
4. 8624019 - ENA nucleic acid drugs modifying splicing in mRNA precursor (2014-01-07),
Orphan Disease Treatment Institute Co., Ltd. is a leading biopharmaceutical company dedicated to developing innovative treatments for rare and orphan diseases. With a focus on research and development, we aim to bring hope to patients suffering from these neglected diseases. Our team of experts is committed to making a difference in the lives of those affected by orphan diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#2,786 in Tokyo

#7,416 in Japan

...
Tokyo, Japan

Orphan Disease Treatment Institute Co., Ltd.

Forward Citations = 101

8 inventors:

goldMedal Makoto Koizumi (4 out of 49 patents)

silverMedal Masafumi Matsuo (4 out of 14 patents)

bronzeMedal Yasuhiro Takeshima (4 out of 6 patents)

4.  Masafumi Matsuo (0 patent)

5.  Makoto Koizumi (0 patent)

Please report any incorrect information to support@idiyas.com
Loading…